Uwe Zeymer

Uwe Zeymer

Auto-generated profile, based on publicly available information

Uwe Zeymer

Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg , Hugstetter Strasse 51, 79106 Freiburg

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in JACC
Verified
Journal Article
Closed access
UZUwe Zeymer
Uwe Zeymer
HSHarry Suryapranata
Harry Suryapranata
JMJean Pierre Monassier
Jean Pierre Monassier
GOGrzegorz Opolski
Grzegorz Opolski
JDJohn Davies
John Davies
KNKarl-Ludwig Neuhaus
Karl-Ludwig Neuhaus

3 October 2023 in Circulation
Verified
Journal Article
Closed access
RWRon Waksman
Ron Waksman
MPMohit Pahuja
Mohit Pahuja
SDSean van Diepen
Sean van Diepen
APAlastair G. Proudfoot
Alastair G. Proudfoot
DMDavid Morrow
David Morrow
WAWilliam T. Abraham
William T. Abraham
The Shock Academic Research Consortium is a multi-stakeholder group, including representatives from the US Food and Drug Administration and other government agencies, industry, and payers, convened to develop pragmatic consensus definitions useful for the evaluation of clinical trials enrolling patients with cardiogenic shock, including trials evaluating mechanical circulatory support devices. Several in-person and virtual meetings were convened between 2020 and 2022 to discuss the need for developing the standardized definitions required for evaluation of mechanical circulatory support devices in clinical trials for cardiogenic shock patients. The expert panel identified key concepts and topics by performing literature reviews, including previous clinical trials, while recognizing current challenges and the need to advance evidence-based practice and statistical analysis to support future clinical trials. For each category, a lead (primary) author was assigned to perform a literature search and draft a proposed definition, which was presented to the subgroup. These definitions were further modified after feedback from the expert panel meetings until a consensus was reached. This manuscript summarizes the expert panel recommendations focused on outcome definitions, including efficacy and safety.

1 February 2004 in European Heart Journal
Verified
Journal Article
Closed access
UZU Zeymer
U Zeymer
Aims Acute myocardial infarction complicated by cardiogenic shock is associated with an exceedingly high mortality, even if patients are treated with early reperfusion therapy. The aim of this study was to evaluate predictors of in-hospital mortality of a large cohort of consecutive patients with cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Methods and results Between July 1994 and March 2001 all interventions performed in 80 centres in Germany were prospectively entered into the primary PCI registry of the ALKK. A total of 9422 procedures were registered, of these 1333 (14.2%) were performed in patients with cardiogenic shock. Total in-hospital mortality was 46.1% and was dependent on TIMI flow grade after PCI, with mortality rates of 78.2%, 66.1% and 37.4% in patients with TIMI 0/1, TIMI 2 and TIMI 3 flow, respectively. In a multivariate analysis left main disease, TIMI <3 flow after PCI, older age, three-vessel disease and longer time-intervals between symptom onset and PCI were significant independent predictors of mortality. The relative number of PCIs performed in patients with cardiogenic shock did not change significantly from 1995-2000. There was a significant decrease in mortality over the years (P for trend 0.02). Conclusions In-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock remains high, even with early interventional therapy. However, our data demonstrate that the PCI in these high-risk patients is feasible in a wide spectrum of community hospitals with acceptable success rates. Our results seen in connection with the results of the randomized SHOCK study advocate an early invasive approach in younger patients with cardiogenic shock, while the best strategy in elderly patients is still a matter of debate.

26 August 2023 in The Lancet
Verified
Journal Article
Closed access
UZUwe Zeymer
Uwe Zeymer
AFAnne Freund
Anne Freund
MHMatthias Hochadel
Matthias Hochadel
POPetr Ostadal
Petr Ostadal
JBJan Belohlavek
Jan Belohlavek
HTHolger Thiele
Holger Thiele

17 October 2007 in European Heart Journal
Verified
Journal Article
Open access
PDF file
TBTimm Bauer
Timm Bauer
OKOliver Koeth
Oliver Koeth
CJClaus Jünger
Claus Jünger
THTobias Heer
Tobias Heer
HWHarm Wienbergen
Harm Wienbergen
FIfor the Acute Coronary Syndromes Registry (ACOS) Investigators
for the Acute Coronary Syndromes Registry (ACOS) Investigators
We sought to investigate the impact of an invasive treatment in elderly patients presenting with non-ST elevation myocardial infarction (NSTEMI) in clinical practice. We analysed data of consecutive elderly patients (≥75 years) with NSTEMI who were prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002. Overall 1936 patients were divided into two groups: 1005 (51.9%) underwent coronary angiography and/or revascularization, 931 (48.1%) received conservative treatment. In the invasive group, percutaneous coronary intervention was performed in 37.5% within 48 h and in 17.6% after 48 h, whereas 9.8% underwent coronary artery bypass grafting within the hospital stay. In-hospital death (12.5 vs. 6.0%, P < 0.0001) and death/myocardial infarction (17.3 vs. 9.6%, P < 0.0001) occurred significantly less often in patients with invasive strategy. After adjustment of the confounding factors in the propensity score analysis the invasive strategy remained superior for mortality (OR 0.55, 95% CI 0.35–0.86) and death and non-fatal myocardial infarction (OR 0.51, 95% CI 0.35–0.75) and 1 year mortality (OR 0.56, 95% CI 0.38–0.81). Major bleeding complications tended to be more frequent in the invasive group (8.8 vs. 5.8%, P = 0.07). In clinical practice, in elderly patients with NSTEMI, an invasive strategy is associated with an improved in-hospital and 1 year outcome but a trend towards more bleeding complications.

21 December 2011 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
UZUwe Zeymer
Uwe Zeymer
HAHans-Richard Arntz
Hans-Richard Arntz
BMBernd Mark
Bernd Mark
SFStephan Fichtlscherer
Stephan Fichtlscherer
GWGerald Werner
Gerald Werner
KHKurt Huber
Kurt Huber